loading
Ginkgo Bioworks Holdings Inc stock is traded at $6.47, with a volume of 63,643. It is down -0.47% in the last 24 hours and down -29.04% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
See More
Previous Close:
$6.36
Open:
$6.46
24h Volume:
63,643
Relative Volume:
0.04
Market Cap:
$363.84M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-9.1127
EPS:
-0.71
Net Cash Flow:
$-387.26M
1W Performance:
-13.41%
1M Performance:
-29.04%
6M Performance:
-78.36%
1Y Performance:
-88.93%
1-Day Range:
Value
$6.26
$6.46
1-Week Range:
Value
$6.01
$7.21
52-Week Range:
Value
$5.26
$75.20

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Name
Ginkgo Bioworks Holdings Inc
Name
Phone
(877) 442-5362
Name
Address
27 DRYDOCK AVENUE, BOSTON
Name
Employee
1,218
Name
Twitter
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
DNA 6.45 363.84M 217.11M -651.19M -387.26M -0.71
VRTX 447.79 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.25 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.72 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.74 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.50 24.49B 3.30B -501.07M 1.03B 11.54

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-24 Downgrade BTIG Research Neutral → Sell
May-10-24 Downgrade William Blair Mkt Perform → Underperform
Nov-14-23 Downgrade Raymond James Outperform → Mkt Perform
Nov-09-23 Downgrade BTIG Research Buy → Neutral
Jun-02-23 Downgrade Goldman Neutral → Sell
May-11-23 Downgrade William Blair Outperform → Mkt Perform
Nov-29-22 Initiated Berenberg Buy
Oct-04-22 Initiated Morgan Stanley Equal-Weight
May-18-22 Downgrade BofA Securities Neutral → Underperform
Mar-02-22 Resumed Cowen Outperform
Feb-23-22 Initiated Goldman Neutral
Feb-01-22 Initiated BofA Securities Neutral
Jan-28-22 Initiated BofA Securities Buy
Jan-07-22 Initiated BTIG Research Buy
Nov-29-21 Initiated Jefferies Buy
Oct-13-21 Initiated Raymond James Outperform
Oct-12-21 Initiated William Blair Outperform
Sep-20-21 Initiated HSBC Securities Buy
View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

pulisher
Nov 20, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Tao Capital Management LP - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

US Bancorp DE Sells 183,450 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

How To Trade (DNA) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 18, 2024

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha

Nov 13, 2024
pulisher
Nov 13, 2024

Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Secures $9M Milestone Payment from Merck Partnership Breakthrough | DNA Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga

Nov 11, 2024
pulisher
Nov 08, 2024

Ginkgo Bioworks chief accounting officer sells $2,522 in stock - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Ginkgo Bioworks chief accounting officer sells $2,522 in stock By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

(DNA) On The My Stocks Page - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 06, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Ginkgo Bioworks (DNA) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

BTIG Downgrades Ginkgo Bioworks Holdings Inc(DNA) - MSN

Nov 06, 2024
pulisher
Nov 05, 2024

Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace

Nov 05, 2024
pulisher
Nov 05, 2024

Ginkgo Bioworks (DNA) Sets Q3 2024 Earnings Call for November 12 | DNA Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance

Nov 03, 2024
pulisher
Oct 31, 2024

Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024
pulisher
Oct 30, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN

Oct 30, 2024
pulisher
Oct 28, 2024

Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 27, 2024
pulisher
Oct 23, 2024

Major Boston biotech company begins layoffs this week - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat

Oct 22, 2024
pulisher
Oct 19, 2024

Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 19, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN

Oct 14, 2024
pulisher
Oct 14, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat

Oct 12, 2024
pulisher
Oct 09, 2024

Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia

Oct 08, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada

Oct 08, 2024

Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):